Unknown

Dataset Information

0

Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue.


ABSTRACT: Glioblastoma (GBM) is the most lethal intracranial tumor. Sequencing technologies have supported personalized therapy for precise diagnosis and optimal treatment of GBM by revealing clinically actionable molecular characteristics. Although accumulating sequence data from brain tumors and matched normal tissues have facilitated a comprehensive understanding of genomic features of GBM, these in silico evaluations could gain more biological credibility when they are verified with in vitro and in vivo models. From this perspective, GBM cell lines with whole exome sequencing (WES) datasets of matched tumor tissues and normal blood are suitable biological platforms to not only investigate molecular markers of GBM but also validate the applicability of druggable targets. Here, we provide a complete WES dataset of 26 GBM patient-derived cell lines along with their matched tumor tissues and blood to demonstrate that cell lines can mostly recapitulate genomic profiles of original tumors such as mutational signatures and copy number alterations.

SUBMITTER: Kim SC 

PROVIDER: S-EPMC10338444 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue.

Kim Soon-Chan SC   Cho Young-Eun YE   Shin Young-Kyoung YK   Yu Hyeon Jong HJ   Chowdhury Tamrin T   Kim Sojin S   Yi Kyung Sik KS   Choi Chi-Hoon CH   Cha Sang-Hoon SH   Park Chul-Kee CK   Ku Ja-Lok JL  

Scientific data 20230712 1


Glioblastoma (GBM) is the most lethal intracranial tumor. Sequencing technologies have supported personalized therapy for precise diagnosis and optimal treatment of GBM by revealing clinically actionable molecular characteristics. Although accumulating sequence data from brain tumors and matched normal tissues have facilitated a comprehensive understanding of genomic features of GBM, these in silico evaluations could gain more biological credibility when they are verified with in vitro and in vi  ...[more]

Similar Datasets

| S-EPMC8772739 | biostudies-literature
2017-09-27 | GSE104291 | GEO
| S-EPMC11313325 | biostudies-literature
| S-EPMC9564145 | biostudies-literature
2020-05-12 | GSE114867 | GEO
| PRJNA412249 | ENA
| S-EPMC10791076 | biostudies-literature
| S-ECPF-MEXP-3200 | biostudies-other
| S-EPMC4459842 | biostudies-literature
2024-10-21 | GSE279426 | GEO